Over the last years, metabolic syndromes such as type 2 diabetes mellitus (T2DM), a chronic disorder characterized by hyperglycaemia and alterations in insulin level and/or insulin action, have been identified as risk factors for PD development [12, 13]. The gene discussed is INS; the disease is type 2 diabetes mellitus.